End-of-day scoring · Prices as of last close
Educational Analytics — No Financial Advice
Scanning 9,000+ Stocks & Crypto
_
89bio Inc
Establishing multi-vendor link for ETNB
This company creates medicines for liver and metabolic diseases, such as NASH and rare disorders. Doctors and patients use these treatments because there are few alternatives available. It makes money by selling approved drugs and forming partnerships with larger pharmaceutical firms for development and distribution.
This company operates in the biotechnology sector, focusing on developing treatments for serious medical conditions like liver diseases. It competes with other biotech firms by targeting niche areas where patient needs are high but options are limited. The industry relies heavily on clinical trial results and regulatory approvals to drive value.
Intelligence Pipeline Active
Our scoring engine is gathering indicator data for this asset. Component breakdowns will appear once analysis is complete.
No active score modifiers detected
Price is overextended from the 20-day trend lead.
Price is extended significantly above 52-week highs.
Extreme volume spike suggests late-stage retail entry.
Banana Farmer tracks 100's of signals to synthesize this proprietary score.
Our engine is currently indexing ETNB across global social channels to detect early sentiment shifts and technical alignment.
Intelligence Narrative Connected
Educational only.
Loading chart...
Loading chart...
Loading chart...
Loading chart...